The revised EU pharmaceutical policy maintains eight-year data protection but reduces market protection to one year, ...

Mike Stenberg, LGM Pharma, outlines how GLP-1s, AI, and 505(b)(2) delivery shifts are driving pharmaceutical innovation.

Researchers have used a cutting-edge robotic system capable of synthesizing hundreds of metal complexes to develop a possible ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...

More than 90% of drugs that appear safe and effective in animal studies ultimately fail once they reach human trials, and the consequences are staggering: billions of dollars wasted, delays in new ...

Jessica Lin and Zhenqi (Pete) Shi from Genentech describe a novel machine learning approach to predicting retention times for ...

G-protein coupled receptors (GPCRs) are proteins triggered by ligands (protein-binding chemicals) from outside cells to ...

PM calls for Buddhism to play stronger role in development process. The Prime Minister has urged the Lao Buddhist Fellowship ...

This effort to accelerate development can be clearly seen in how the agency is approaching biosimilars. In October 2025, the FDA issued a guidance update indicating that “switching” studies — a trial ...

Residents of Somalia’s capital are set to vote Thursday in a controversial local election that marks the country’s first-ever ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.